Dies ist ein Teil einer Emailkorrespondenz zwischen einem Wissenschaftler/Doktor in Amerika und einer überlebenden Krebspatientin in Schottland.

Dezember 2009

Hi Dr Z…,
you might remember me writing to you some weeks ago. I have NSCLC with which I was diagnosed in 2006. At that time I received palliative care only. I have been on LDN for the last two years with no sign yet of recurrance. However, some people simply don't respond. Could this be because they do not have functioning genes for OGF receptors? Is there any way around this? Could you explain about this to me a little more?


First, how wonderful to hear you are doing well with LDN and your disease. NSCLC is deadly - for you to be here. If you have stage IV this is very bad. So, LDN is working wonders. Second, why some people don't respond. Now we are entering the arena of what needs to be done. More research. Predictions in humans, because of their variability in genetics, metabolism, environment, etc. is extremely difficult. We have learned an awful lot about LDN - its chemistry, biological pathways, and cell/molecular biology. I could name 50 factors right now that could make a difference based on our science to date. If we knock these factors (one at a time) out, we can stop the action of OGF (the opioid growth factor - how LDN really does its job) or LDN. Not to mention the quality of the LDN - especially the fillers used in its composition. Then the type of disease and stage of disease need to be factored into an assessment.

Please keep up the LDN - and your good health. I am proud of you - and delighted that we discovered something that helped another person.